Melissa Siegfried

Doctor of Osteopathic Medicine,  The Johns Hopkins Hospital 

Location: Germany

Consulting Services

Case Consulting Biostatistics Career Advice and Mentoring Scientific Writing

Areas Of Interest

Endopeduncularis, Nucleus Juvenile Onset Vitelliform Macular Dystrophy Sodium Isotopes Canal, Inguinal Male Urethral Sling Infectious Laryngotracheitis like Viruses Gait Disorders, Animal Capuchin, White-Throated Therapy-Resistant Depressions Technique, Decalcification Epiphora Digestive System Phenomenon Osteoma Civil Disorder Feeding Tube, Gastric Columba livia Lumbar Osteoarthritis Autoimmune Hypophysitides Permapen Cysts, Branchial Product, Vegetable Calcium Activated Protease Bovine Lymphoma Pyridoxine Kinase Integrin alpha IIb beta 3 Chondroitin Eliminase Polyradiculoneuropathy, Chronic Inflammatory Tumors, Hypothalamic Poly(A)+ mRNA Binding Protein Type 5, Phosphodiesterase Ephrin-A1 Cervical Rib Syndrome Essences, Flower People 2020, Healthy Food, Cultured ets-Domain Protein Elk-4 Swallows

Professional Narrative

Dr. Melissa Siegfried was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Siegfried has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.

Employment

Executive Director, Harvard Med 1991
Executive Director, Harvard Med 1990

Education

Master of Science in physician assistant, Baylor College 1998
Doctor of osteopathic medicine, Yale School of Medicine 1994

Referees

Publications

Gupta A, Andresen JL, Manan RS, Langer R. Nucleic acid delivery for therapeutic applications. Adv Drug Deliv Rev. 2021 Nov;178:113834. doi: 10.1016/j.addr.2021.113834. Epub 2021 Sep 4. PMID: 34492233.

Tang Z, Kong N, Zhang X, Liu Y, Hu P, Mou S, Liljeström P, Shi J, Tan W, Kim JS, Cao Y, Langer R, Leong KW, Farokhzad OC, Tao W. A materials-science perspective on tackling COVID-19. Nat Rev Mater. 2020;5(11):847-860. doi: 10.1038/s41578-020-00247-y. Epub 2020 Oct 14. PMID: 33078077; PMCID: PMC7556605.

Gupta A, Andresen JL, Manan RS, Langer R. Nucleic acid delivery for therapeutic applications. Adv Drug Deliv Rev. 2021 Nov;178:113834. doi: 10.1016/j.addr.2021.113834. Epub 2021 Sep 4. PMID: 34492233.

Riley RS, June CH, Langer R, Mitchell MJ. Delivery technologies for cancer immunotherapy. Nat Rev Drug Discov. 2019 Mar;18(3):175-196. doi: 10.1038/s41573-018-0006-z. PMID: 30622344; PMCID: PMC6410566.

Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :

Languages

Language Proficiency :

Translation Services :

Serving Millions of physicians and biomedical scientists in Industry and academia.

Site
Services
Follow Us
Contact Us
  • support@scienceandminds.com

Copyright © 2025 Trialect Inc. All rights reserved. | v2023.06.17.02